3Rabe KF, Hurd S, Anzueto A,et al. Global strategy for the diagnosis,management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med,2007,176 : 532-555.
4Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome .9 Lancet,2007,370 : 797-799.
5Agusti AG, Noguera A, Sauleda J, et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J,2003, 21:347-360.
7Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation:a systematic review and a meta-analysis. Thorax, 2004,59 : 574 -580.
8Sevenoaks MJ,Stockley RA. Chronic Obstructive Pulmonary Disease,inflammation and co-morbidity-a common inflammatory phenotype? Respir Res,2006 ,7 :70.
9Veruooy JH, Kucukaycan M ,Jacobs JA, et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease:soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med,2002, 166 : 1218-1224.
10Hurst JR, Wilkinson TM, Perera WR, et al. Relationships among bacteria, upper airway, lower airway, and systemic inflammation in COPD. Chest,2005,127 : 1219-1226.
